Clinical trial · Observational
The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators will evaluate the prevalence of lung cancer associated with interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) utilizing the Korean Health Insurance Review and Assessment Service (HIRA) database, spanning the period from January 2011 to December 2011. The database (HIRA-NPS-2011-0001) was based on random sampling of outpatients from whole population. Patients with ILDs, IPF, connective tissue disorder (CTD), and COPD were identified based on the International Classification of Disease-10 (ICD-10) diagnostic codes.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Lung Diseases, Interstitial | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (11)
- label
- Lung cancer in population
- description
- Lung cancer cases in sample population (670,258 cases)
- label
- COPD in population
- description
- COPD cases (670,258 cases)
- label
- COPD with lung cancer
- description
- Lung cancer in COPD
- label
- ILD without IPF
- description
- Interstitial lung disease (ILD) cases without idiopathic pulmonary fibrosis (IPF)
- label
- ILD with lung cancer
- description
- Lung cancer cases in ILD
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * equal to above 40 years old Exclusion Criteria: * none
References
Publications (0)
Data not yet available